The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network.

"Declaration of competing interest MRC reports consultancy fees from Servier, AstraZeneca, Medtronic, Abbott, Philips, and Roche Diagnostics. RMR has received consultancy fees and speaker honoraria from Servier, AstraZeneca, Boehringer Ingelheim, Bayer and Novartis. CF has received consultancy fees, grants and speaker honoraria from AstraZeneca, Bayer, Bial, Boehringer Ingelheim, Novartis, Roche, Sanofi, Servier and Vifor Pharma. YL has received consulting and speaker fees from Boehringer Ingelheim, Servier, MSD, and Novartis. EBR has received consulting fees from E. Merck, Pfizer, Innogen, Servier, and Torrent, speaker fees from AstraZeneca, Corbridge, Servier, Pfizer, E. Merck, Novartis, Innogen, and Boehringer Ingelheim, and research grants from Novartis and Corbridge. CS has received speaker honoraria from Servier, AstraZeneca, Boehringer Ingelheim, Novartis, Medtronic, Bayer and Merck, consulting fees from Servier, Bayer, AstraZeneca, Merck and Novartis, and honoraria as a principal investigator from Bayer, Novartis, and Merck. PS has received honoraria from Servier, Novartis, Bayer, AstraZeneca and Boehringer Ingelheim. SZ has received research grant support or served on advisory boards for Abbott, Akcea, AstraZeneca, Amgen, Alnylam, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Otsuka, Pfizer, Servier, and Vifor, she has speaker engagements Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli-Lilly, Novartis, Novo Nordisk, Servier, and Vifor, and she serves on a clinical trial steering committee or as a national lead for studies sponsored by AstraZeneca, Bayer, Boehringer Ingelheim, Merck and Novartis. HYC, MV, HNB, DCDA, EC, JAMS, LM, GAMP, ZP, DSKL, MT, and YTY have no competing interests to declare."

"Funding The OPTIMIZE Heart Failure Care program is funded by 10.13039/501100011725Servier, which provided support for writing assistance and the organization of working group meetings."